# Clinical Performance Evaluation of DxN HBV Assay

> **NCT03123159** · — · TERMINATED · sponsor: **Beckman Coulter, Inc.** · enrollment: 60 (actual)

## Conditions studied

- Hepatitis B

## Interventions

- **DIAGNOSTIC_TEST:** DxN HBV Assay

## Key facts

- **NCT ID:** NCT03123159
- **Lead sponsor:** Beckman Coulter, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2014-05-27
- **Primary completion:** 2017-08-30
- **Final completion:** 2017-08-30
- **Target enrollment:** 60 (ACTUAL)
- **Why stopped:** Business decision
- **Last updated:** 2018-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03123159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03123159, "Clinical Performance Evaluation of DxN HBV Assay". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03123159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*